Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Other financing activities: 2009-2024

Historic Other financing activities for Fortress Biotech (FBIO) over the last 13 years, with Dec 2024 value amounting to -$1,000.

  • Fortress Biotech's Other financing activities was N/A to -$2,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7,000, marking a year-over-year change of. This contributed to the annual value of -$1,000 for FY2024, which is N/A change from last year.
  • Per Fortress Biotech's latest filing, its Other financing activities stood at -$1,000 for FY2024, which was down 100.57% from $174,000 recorded in FY2022.
  • Over the past 5 years, Fortress Biotech's Other financing activities peaked at $278,000 during FY2021, and registered a low of -$1,000 during FY2024.
  • In the last 2 years, Fortress Biotech's Other financing activities had a median value of $86,500 in 2022 and averaged $86,500.
  • As far as peak fluctuations go, Fortress Biotech's Other financing activities plummeted by 95.78% in 2020, and later soared by 1,444.44% in 2021.
  • Yearly analysis of 4 years shows Fortress Biotech's Other financing activities stood at $18,000 in 2020, then surged by 1,444.44% to $278,000 in 2021, then slumped by 37.41% to $174,000 in 2022, then reached -$1,000 in 2024.